SI
SI
discoversearch

We've detected that you're using an ad content blocking browser plug-in or feature. Ads provide a critical source of revenue to the continued operation of Silicon Investor.  We ask that you disable ad blocking while on Silicon Investor in the best interests of our community.  If you are not using an ad blocker but are still receiving this message, make sure your browser's tracking protection is set to the 'standard' level.
Biotech / Medical : VVUS: VIVUS INC. (NASDAQ)
 Public ReplyPrvt ReplyMark as Last ReadFilePrevious 10Next 10PreviousNext  
To: DR. BOND who wrote (3139)12/9/1997 9:42:00 PM
From: BigKNY3  Read Replies (1) of 23519
 
Dr. Bond <<BigKNY3 need not respond as these rumors are just that..RUMORS.>>

Hey, Doc. You know I could not resist placing some facts to Viagra rumors.The Viagra Phase III studies of over 4,500 patients have been completed and are currently being priority reviewed by the FDA. The summary of side effects has already been announced with a discontinuance rate of 2% equal to placebo. The major side effects were headaches and flushing.

Any ongoing Viagra studies are Phase IIIB studies that probably began in the Fall, 1997 and will be completed after the FDA approval. Accordingly, it is highly doubtful that these studies in such early stages are "not going as well as believed".

BigKNY3
Report TOU ViolationShare This Post
 Public ReplyPrvt ReplyMark as Last ReadFilePrevious 10Next 10PreviousNext  

HomeMailHotSubjectMarksPeopleMarksKeepersSettings
Terms Of UseContact UsCopyright/IP PolicyPrivacy PolicyAbout UsFAQAdvertise on SI
© 2025 Knight Sac Media.  Data provided by Twelve Data, Alpha Vantage, and CityFALCON News